In Glaucoma Saflutan Eye Drop is a medicine used to reduce pressure in your eyes (ocular hypertension). This pressure can lead to an illness called glaucoma. If the pressure in your eye is too high, it can damage your sight. This medicine works by helping the fluid to flow from inside the eye into your bloodstream. It may be used alone or with other eye drops. Do not use it too often as that can make it less effective. You should only use it in the affected eye and take it regularly as prescribed by your doctor. If you stop taking it, the pressure in your eye will not be controlled. This could lead to a loss of sight. In Ocular hypertension Saflutan Eye Drop belongs to a group of medicines called prostaglandin analogue. It is used to reduce pressure in your eyes. It increases the flow of fluid from inside the eye into the bloodstream thereby lowering the increased eye pressure. If the pressure in your eye is too high, it can damage your sight. You should only use it in the affected eye and take it regularly as prescribed by your doctor. If you stop taking it, the pressure in your eye will not be controlled.
No interaction found/established
Saflutan Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Saflutan Eye Drop should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
It is not known whether Saflutan Eye Drop alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
No interaction found/established
No interaction found/established
If you miss a dose of Saflutan Eye Drop, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Santen India Pvt Ltd || ₹14.5/tablet (25% cheaper)